EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reviewing the thoroughness of human safety testing for succinate dehydrogenase inhibitors: fluopyram as a case study

Kim Z Travis iD, Rémi Bars iD, Helen Tinwell iD

Archives of Toxicology · 2026

DOI: 10.1007/s00204-025-04279-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Toxicology, 2026. Verfasst von Kim Z Travis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Regulatory Science Associates, Largs Yacht Haven, Irvine Road, Largs, KA30 8EZ, UK. kim.travis@regulatoryscience.com. Hauptthemen laut MEDLINE: Succinate Dehydrogenase, Pyridines, Fungicides, Industrial, Enzyme Inhibitors. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bayer CropScience.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been suggested that fungicides which are succinate dehydrogenase inhibitors also inhibit this enzyme in humans, with potentially serious health consequences. It has also been suggested that regulatory studies conducted on these fungicides have missed succinate dehydrogenase inhibition and its effects. Using fluopyram as a case study, this paper addresses these suggestions by critically examining all the studies related to human safety. The mechanism causing each toxicity is considered, including the possibility that inhibition of succinate dehydrogenase might be the root cause. If fluopyram were to inhibit succinate dehydrogenase, then the consequent effects and their likelihood of detection are evaluated. Many fluopyram toxicity studies are completely untargeted, with a huge number of endpoints examined, any one of which might reveal an important toxic effect. Rat and mouse studies from a single dose to near lifetime exposure are included, whilst dog studies add biological coverage. The consistent pattern seen is that the primary toxicities caused by fluopyram are effects on the liver and thyroid, plus a kidney effect in ageing male rats. The mechanisms causing these effects have been proven in bespoke mechanistic studies-they are not relevant to humans and do not involve the inhibition of succinate dehydrogenase. If fluopyram were to inhibit succinate dehydrogenase then this would be apparent, as the tissues most likely to be affected-the nervous system, heart and muscle-were examined microscopically in numerous studies with no effects seen. The low affinity of fluopyram for mammalian succinate dehydrogenase and its rapid metabolism explain the results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Succinate DehydrogenasePyridinesFungicides, IndustrialEnzyme InhibitorsToxicity TestsAniline CompoundsAnimalsHumansMaleRatsDogsMiceBenzamides

Stichwörter der Autor:innen

FluopyramSuccinate dehydrogenaseToxicology

Substanzen

Succinate DehydrogenaseN-(2-(3-chloro-5-(trifluoromethyl)-2-pyridyl)ethyl)-alpha,alpha,alpha-trifluoro-o-toluamidePyridinesFungicides, IndustrialEnzyme InhibitorsAniline CompoundsBenzamides

Autor:innen und Institutionen

  • Regulatory Science Associates, Largs Yacht Haven, Irvine Road, Largs, KA30 8EZ, UK. kim.travis@regulatoryscience.com.
  • Regulatory Science Associates, Largs Yacht Haven, Irvine Road, Largs, KA30 8EZ, UK.
  • Bayer SAS, 16 Rue Jean-Marie Leclair, 69009, Lyon, France.
  • Bayer SAS, 16 Rue Jean-Marie Leclair, 69009, Lyon, France. helen.tinwell@bayer.com.

ORCID-Profile: Kim Z Travis, Rémi Bars, Helen Tinwell

Förderung

  • Bayer CropScience

Zitieren

APA

Travis, K. Z., Bars, R., & Tinwell, H. (2026). Reviewing the thoroughness of human safety testing for succinate dehydrogenase inhibitors: fluopyram as a case study. Archives of Toxicology. https://doi.org/10.1007/s00204-025-04279-7

Vancouver

Travis KZ, Bars R, Tinwell H. Reviewing the thoroughness of human safety testing for succinate dehydrogenase inhibitors: fluopyram as a case study. Archives of Toxicology. 2026. doi:10.1007/s00204-025-04279-7

BibTeX
@article{Travis2026,
  author = {Travis, Kim Z and Bars, Rémi and Tinwell, Helen},
  title = {Reviewing the thoroughness of human safety testing for succinate dehydrogenase inhibitors: fluopyram as a case study},
  journal = {Archives of Toxicology},
  year = {2026},
  doi = {10.1007/s00204-025-04279-7}
}
Kostenlos starten →